Control of Gene Expression Flashcards

1
Q

Repressor and Activators

A
  • Repressors inhibit transcription
  • Activators promote transcription
  • Regulatory proteins are allosteric: possess sites that can be bound by both, separate from active site
  • Can enhance or diminish activity of activator or repressor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Positive Transcriptional Regulation

A
  • When activator binds, facilitate recruitment of RNA polymerase and enhance activity of downstream gene
  • Ligand can inactivate activator and dissociate from DNA
  • Other activators require ligand to activate transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Negative transcriptional regulation

A
  • Repressor binds promoter -> inhibit RNAP binding
  • Absence of repressor binding can transcription occur
  • Presence of ligand can dissociate repressor and initiate transcription
  • Other repressors need ligand to inhibit transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lac operon in prokaryotes

A
  • Operon is functional unit of genomic DNA that consist of cluster of genes under single pronoter
  • Lac operon is for metabolization of lactose to glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lac operon structure

A
  • Transcriptional control region: Contains promoter for RNAP binding and operator for repressor binding
  • Three related structural genes: lac z, lac y, lac a
  • Upstream of lac operon is regulatory gene with lac i repressor -> cannot metabolize lactose -> lac i binds to operator region and inhibit expression
  • Lac z encode beta-galactoside, Lac y encode transport protein galactosidase permease (brings lactose into cell), lac a encodes galactosidase transacetylase (acetylates any unhydrolyzed lactose for elimination)
  • Direct relationship between lac operon and cell growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Negative regulation of lac operon

A
  • Lac i repressor binds as dimer to operator region preventing RNAP from transcribing lac z, y, a
  • One dimerized repressor binds to upstream promoter and another to downstream
  • Forms tetrameric protein structure: DNA loop
  • Repressors recognition helix contains arginine residues that transiently H-bond with base pairs of DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ligand binds repressor

A
  • When lactose present, lac i dissociates
  • Allolactose binds repressor, induces disorganization of repressor recognition helix, reducing affinity -> repressor dissociates
  • Allolactose made from side reaction of lactose, beta-galactosidase changes glycosidic link between lactose monomers from 1-4 to 1-6
  • High lactose in cell, high allolactose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Positive regulation of lac operon

A
  • When glucose absent, cells increase expression of lac operon using catabolite active repressor (CAP)
  • CAP is dimeric protein, when activated, bind to DNA via C terminus, and N terminus bind to ligand cAMP, active when binded to two molecules of cAMP
  • CAP bind upstream of lac promoter and assist in forming closed promoter complex to initiate transcription
  • Amount of cAMP and glucose in cell inversely related
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DNA binding proteins in eukaryotes

A
  • DNA binding proteins recognize specific DNA sequences
  • 80% of DNA binding proteins characterized with helix turn helix, zinc finger, leucine zipper
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Helix turn helix

A
  • Composed of several alpha helices
  • Recognition helix that interacts with major groove of DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Zinc finger

A
  • Consist of zinc ion coordinated to two conserved histidines and cysteines
  • Allow DNA binding protein to fold into compact structure, allowing for zinc finger alpha helix to interact with major groove
  • Amino acids in helix bind to bases via H-bonds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Leucine zipper

A
  • DNA binding regions: Consist of basic residues of lysine and arginine, which are positively charged. Allow to interact with negatively charge backbone of DNA
  • Connector region: 6 amino acid connector that hold DNA binding and zipper regions together
  • Leucine zipper: Coiled structure formed by hydrophobic interactions between two alpha helices. Driven by hydrophobic leucine residues in both helices once every 7 amino acids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Structure of estrogen and estrogen receptor

A
  • Estrogen is hormone derived from cholesterol, acts as ligand to estrogen receptor
  • Estrogen receptor is soluble and found in nucleus of cell, undergoes conformational change upon ligand binding, subsequently able to bind coactivator
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Estrogen receptor structure

A
  • Transcription activation region: Helix 12 folds onto side of receptor and co activator able to bind to transcriptor activation region
  • DNA binding region: Two zinc fingers bind to consensus sequence called estrogen receptor elements. bind as a dimer
  • Hormone binding pocket: Hormone binding regions forms pocket that estrogen can bind to
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Transcriptional activation via estrogen receptor

A
  • Receptor can bind DNA in presence or absence of ligand
  • Estrogen binding induces conformational change in ER
  • Co activator facilitates remodeling of chromatin bound by ER, allowing for RNAP binding, enhancing transcription of ER specific genes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drugs targeting hormone receptors

A
  • Estradiol is type of estrogen hormone that acts as agonist of estrogen receptor -> receptor signaling pathway initiated
  • Tamoxifen is antagonist, has hydrophobic rings that allow it to fit into ER binding pocket. Blocks H12 from folding, blocking co activator recruitment -> inhibit gene expression
  • Tamoxifen used as breast cancer treatment
17
Q

rRNA processing

A
  • RNA Polymerase 1 synthesizes single precursor rRNA including 18S, 5.8S, and 28S rRNAs
  • 5.8S and 28S incorporated into large ribosomal subunit, and 18S in smaller subunit
  • Nucleotide modifications made by small nucleolar ribonucleoproteins (snoRNPs)
  • snoRNP complexes composed of rRNA and proteins modify base by adding methyl groups and converting uracils to psuedouracils
  • Non modified spacer regions cleaved to produce the three mature rRNA molecules
18
Q

tRNA

A
  • Synthesized by RNA Polymerase III
  • RNAse P cleaves leader region at 5’ end
  • RNAse D cleave trailer region at 3’ end
  • Amino acid attachment site added at 3’ end by tRNA nucleotidyl transferase
  • Base modification made: methylation of D loop and formation of psuedouridine
  • Intron near anticodon loop spliced to generate anticodon
19
Q

mRNA

A
  • Synthesized by RNA Polymerase II
  • Eukaryotic mRNA exclusively monocistronic, each mRNA molecule only encodes one polypeptide product
  • Prokaryote mRNA is polycistronic
20
Q

Capping

A
  • 7-methyl G cap at 5’ end consist of guanine methylated at position 7. m7G not part of original transcript, connected by unique 5’-5’ triphosphate bond
  • Several bases at 5’ end are methylated at 2’-OH position, are part of mRNA sequence
  • Capping process begins while RNA polymerase still transcribing mRNA
  • Added cap increase stability and protect mRNA
  • Guanyl transferases: Guanyl transferase hydrolyzes gamma phosphate from 5’ end of transcript to release phosphate. Oxygen of 5’ beta phosphate attacks alpha phosphate of GTP causing release of pyrophosphate. Creates 5’-5’ triphosphate bond. Not yet methylated
  • S-adenosyl methionine: SAM is cosubstrate that serve as source of methyl group for cap. Cap 0 methylated at position 7 of purine ring. Downstream nucleotides methylated at 2’OH position of ribose sugars
21
Q

Poly(A) tail

A
  • Added at 3’ end through polyadenylation
  • RNA polymerase stalling: Stalls at invariant U/G site located 10-35 nucleotides beyond poly A addition sequence(AAUAAA). Prompts recruitment of Cleavage and Polyadenylation Specificity Factor (CPSF) to mRNA
  • Looping of transcript: CPSF binds to consensus sequence and invariant G/U causing looping
  • mRNA cleavage: CPSF recruit cleavage factors CFs to cleave looped portion, transcript synthesized past Poly(A) is released
  • Addition of poly(A) tail: CF dissocate after cleavage, CPSF recruit poly(A) adenylation protein to 3’ end. PAP adds 80-250 non template adenine
  • Release of mature mRNA transcript: CPSF dissociates and leaves transcript with both 5’ and 3’ modifications
22
Q

RNA editing

A
  • Specific nucleotides can be modified
  • Increase protein diversity by altering amino acid
  • Apolipoprotein (fatty acid and steroid transport protein): in liver, remain unedited to translate full lenght ApoB-100 protein with lipoprotein binding domain and LDL receptor
  • If in small intestine, specific cytosine deaminated to uracil, introduces premature stop codon, producing ApoB-48 without LDL receptor domain
23
Q

Splicing

A
  • Alternative splicing allows mRNA to be spliced in ways including or excluding different exons. Result in 2n isoforms, where n is number of exons
  • Constitutive splicing removes introns and ligates exons. Require invariant 5’ GU splice site, key A residue branch site, pyrimidine tract near 3’ end, invariant 3’ AG splice site
  • Occurs in two transesterification reactions. Reactions break phospho-ester bond between nucleotides and reforms new bond with different nucleotides
  • Rely on small nuclear ribonuclear proteins (snRNPs), consist of snRNA and proteins: key U1, U2, U4, U5, U6 form spliceosome
24
Q

Mechanism

A
  • Recognition of 5’ splice site: U1 snRNP contain specific snRNA with six conserved nucleotides -> base pair with 5’ splice site. Only ATP independent step
  • Recognition of branch site: U2 binds to branch site, require one molecule of ATP for hydrolysis
  • Complex binding: U4, U5, U6 complex replaces U1, U1 dissociates. One molecule of ATP used to make complex, second ATP used to facilitate binding
  • Dissociation of U4: Once U5 is aligned at 5’ splice site, U4 dissociates. U2 + U6 catalytic site form across intro via base pairing interactions. U4 act as inhibitor, masks activity of U6 and prevent formation of catalytic site. One molecule of ATP consumed
  • First transesterification reaction: U5 use one ATP to align 2’OH of A branch site to 5’ splice site. Breaks phosphodiester bond at 5’ site resulting in lariat intermediate. Adenine nucleotide of lariat intermediate has 5’-3’, 3’-5’, 2’-5’ phosphodiester linkages
  • Second TE reaction: U5 align 3’OH of exon 1 to 3’ splice site using ATP. Reaction break phosphodiester bond between end of intron and beginning of exon 2, form bond between exon 1 and 2. Form lariat intron and splice product
  • Release of lariat: U5, U6, and U2 and lariat require single molecule of ATP to dissociate. Final ATP required for dissociation at catalytic center.
  • After splicing complete, ATP dependent helicase unwind RNA duplex formed by U6 and U2 facilitating dissociation
25